Chondrocytes lacking WNK2 have a significant downregulation of pathways associated with OA, rheumatoid arthritis, immunogenic cell death and fibrosis, and this response is not abrogated by hyperosmotic treatment (figure 3). The gene discussed is WNK2; the disease is rheumatoid arthritis.